Amiloride inhibits the growth of human colon cancer cells in vitro

J. Y. Koo; D. Parekh; C. M. Townsend; R. Saydjari; B. M. Evers; A. Farre; J. Ishizuka; J. C. Thompson

doi:10.1016/0960-7404(92)90040-R

Amiloride inhibits the growth of human colon cancer cells in vitro

J. Y. Koo, D. Parekh, C. M. Townsend, R. Saydjari, B. M. Evers, A. Farre, J. Ishizuka, J. C. Thompson

Research output: Contribution to journal › Article › peer-review

14 Scopus citations

Abstract

Cytoplasmic alkalinization induced by activation of the Na⁺ H⁺ antiport plays an essential role in the initiation of cell proliferation. In the present study we examined the effects of amiloride, a specific and reversible inhibitor of Na⁺ H⁺ antiporter, on the growth of human colon cancer cells (HT-29). Amiloride (50-800 μm) inhibited the growth of HT-29 cells in a dose-dependent fashion. Forty-three percent inhibition of growth was found at an amiloride concentration of 400 μm after 4 days of treatment. The inhibitory effect of amiloride on growth of HT-29 cells was reversible since removal of amiloride by a media change after 48 h treatment lead to rapid regrowth to control levels. The reversibility of growth inhibition suggests that amiloride is not a non-specific cytotoxin for HT-29 cells. We examined the possible mechanisms for the inhibitory effects of amiloride. Amiloride (400 μM) completely abolished serum-stimulated ODC activity and inhibited difluoromethylornithine (DMFO)-stimulated putrescine uptake by 56%. We conclude that amiloride inhibits the in vitro growth of human colon cancer cells; since ODC-activity and polyamine transport were both inhibited, the inhibitory effects may be mediated in part by polyamine-dependent processes. Amiloride may be a useful agent in the treatment of colon cancer.

Original language	English
Pages (from-to)	385-389
Number of pages	5
Journal	Surgical Oncology
Volume	1
Issue number	6
DOIs	https://doi.org/10.1016/0960-7404(92)90040-R
State	Published - Dec 1992

Bibliographical note

Funding Information:
Correspondence: Courtney M. Townsend, Jr, MD, Department of Surgery, The University of Texas Medical Branch, Galveston, Texas 77555, USA. *Visiting scientist from The Department of Internal Medicine, Kosin Medical College, Pusan, Korea. tvisiting surgeon from the University of Witwatersrand, Johannesburg, South Africa, supported by scholarship from the Michael and Janie Miller Foundation and Medical Research Council, South Africa. This work was supported by grants from the American Cancer Society (PDT-220) and the National Institutes of Health (NIH) PO1 DK 35608, 5R37 DK 15241).

Keywords

amiloride
antiport
colon cancer
difluoromethylornithine
ornithine decarboxylase
putrescine

ASJC Scopus subject areas

Surgery
Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/0960-7404(92)90040-R

Cite this

@article{43426d5deb4b4a1a9f17381143023aee,

title = "Amiloride inhibits the growth of human colon cancer cells in vitro",

abstract = "Cytoplasmic alkalinization induced by activation of the Na+ H+ antiport plays an essential role in the initiation of cell proliferation. In the present study we examined the effects of amiloride, a specific and reversible inhibitor of Na+ H+ antiporter, on the growth of human colon cancer cells (HT-29). Amiloride (50-800 μm) inhibited the growth of HT-29 cells in a dose-dependent fashion. Forty-three percent inhibition of growth was found at an amiloride concentration of 400 μm after 4 days of treatment. The inhibitory effect of amiloride on growth of HT-29 cells was reversible since removal of amiloride by a media change after 48 h treatment lead to rapid regrowth to control levels. The reversibility of growth inhibition suggests that amiloride is not a non-specific cytotoxin for HT-29 cells. We examined the possible mechanisms for the inhibitory effects of amiloride. Amiloride (400 μM) completely abolished serum-stimulated ODC activity and inhibited difluoromethylornithine (DMFO)-stimulated putrescine uptake by 56%. We conclude that amiloride inhibits the in vitro growth of human colon cancer cells; since ODC-activity and polyamine transport were both inhibited, the inhibitory effects may be mediated in part by polyamine-dependent processes. Amiloride may be a useful agent in the treatment of colon cancer.",

keywords = "amiloride, antiport, colon cancer, difluoromethylornithine, ornithine decarboxylase, putrescine",

author = "Koo, {J. Y.} and D. Parekh and Townsend, {C. M.} and R. Saydjari and Evers, {B. M.} and A. Farre and J. Ishizuka and Thompson, {J. C.}",

note = "Funding Information: Correspondence: Courtney M. Townsend, Jr, MD, Department of Surgery, The University of Texas Medical Branch, Galveston, Texas 77555, USA. *Visiting scientist from The Department of Internal Medicine, Kosin Medical College, Pusan, Korea. tvisiting surgeon from the University of Witwatersrand, Johannesburg, South Africa, supported by scholarship from the Michael and Janie Miller Foundation and Medical Research Council, South Africa. This work was supported by grants from the American Cancer Society (PDT-220) and the National Institutes of Health (NIH) PO1 DK 35608, 5R37 DK 15241).",

year = "1992",

month = dec,

doi = "10.1016/0960-7404(92)90040-R",

language = "English",

volume = "1",

pages = "385--389",

number = "6",

}

TY - JOUR

T1 - Amiloride inhibits the growth of human colon cancer cells in vitro

AU - Koo, J. Y.

AU - Parekh, D.

AU - Townsend, C. M.

AU - Saydjari, R.

AU - Evers, B. M.

AU - Farre, A.

AU - Ishizuka, J.

AU - Thompson, J. C.

N1 - Funding Information: Correspondence: Courtney M. Townsend, Jr, MD, Department of Surgery, The University of Texas Medical Branch, Galveston, Texas 77555, USA. *Visiting scientist from The Department of Internal Medicine, Kosin Medical College, Pusan, Korea. tvisiting surgeon from the University of Witwatersrand, Johannesburg, South Africa, supported by scholarship from the Michael and Janie Miller Foundation and Medical Research Council, South Africa. This work was supported by grants from the American Cancer Society (PDT-220) and the National Institutes of Health (NIH) PO1 DK 35608, 5R37 DK 15241).

PY - 1992/12

Y1 - 1992/12

N2 - Cytoplasmic alkalinization induced by activation of the Na+ H+ antiport plays an essential role in the initiation of cell proliferation. In the present study we examined the effects of amiloride, a specific and reversible inhibitor of Na+ H+ antiporter, on the growth of human colon cancer cells (HT-29). Amiloride (50-800 μm) inhibited the growth of HT-29 cells in a dose-dependent fashion. Forty-three percent inhibition of growth was found at an amiloride concentration of 400 μm after 4 days of treatment. The inhibitory effect of amiloride on growth of HT-29 cells was reversible since removal of amiloride by a media change after 48 h treatment lead to rapid regrowth to control levels. The reversibility of growth inhibition suggests that amiloride is not a non-specific cytotoxin for HT-29 cells. We examined the possible mechanisms for the inhibitory effects of amiloride. Amiloride (400 μM) completely abolished serum-stimulated ODC activity and inhibited difluoromethylornithine (DMFO)-stimulated putrescine uptake by 56%. We conclude that amiloride inhibits the in vitro growth of human colon cancer cells; since ODC-activity and polyamine transport were both inhibited, the inhibitory effects may be mediated in part by polyamine-dependent processes. Amiloride may be a useful agent in the treatment of colon cancer.

AB - Cytoplasmic alkalinization induced by activation of the Na+ H+ antiport plays an essential role in the initiation of cell proliferation. In the present study we examined the effects of amiloride, a specific and reversible inhibitor of Na+ H+ antiporter, on the growth of human colon cancer cells (HT-29). Amiloride (50-800 μm) inhibited the growth of HT-29 cells in a dose-dependent fashion. Forty-three percent inhibition of growth was found at an amiloride concentration of 400 μm after 4 days of treatment. The inhibitory effect of amiloride on growth of HT-29 cells was reversible since removal of amiloride by a media change after 48 h treatment lead to rapid regrowth to control levels. The reversibility of growth inhibition suggests that amiloride is not a non-specific cytotoxin for HT-29 cells. We examined the possible mechanisms for the inhibitory effects of amiloride. Amiloride (400 μM) completely abolished serum-stimulated ODC activity and inhibited difluoromethylornithine (DMFO)-stimulated putrescine uptake by 56%. We conclude that amiloride inhibits the in vitro growth of human colon cancer cells; since ODC-activity and polyamine transport were both inhibited, the inhibitory effects may be mediated in part by polyamine-dependent processes. Amiloride may be a useful agent in the treatment of colon cancer.

KW - amiloride

KW - antiport

KW - colon cancer

KW - difluoromethylornithine

KW - ornithine decarboxylase

KW - putrescine

UR - http://www.scopus.com/inward/record.url?scp=0027104397&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027104397&partnerID=8YFLogxK

U2 - 10.1016/0960-7404(92)90040-R

DO - 10.1016/0960-7404(92)90040-R

M3 - Article

C2 - 1341275

AN - SCOPUS:0027104397

SN - 0960-7404

VL - 1

SP - 385

EP - 389

JO - Surgical Oncology

JF - Surgical Oncology

IS - 6

ER -

Amiloride inhibits the growth of human colon cancer cells in vitro

Abstract

Bibliographical note

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this